Settlement Amount: $2.05 Million (Jury Verdict 2024)
Injury Type: Skull-Base Meningioma, Facial Paralysis, Cognitive Decline
Background
Rachil, 41, used Depo-Provera for 11 years before developing right-side facial drooping in 2022. Scans showed a tennis ball-sized meningioma eroding her skull base.
Medical and Emotional Toll
- Facial nerve graft surgery left permanent asymmetry
- Short-term memory loss prevents her working as a CPA
- $1.1 million in medical costs (2 craniotomies, cognitive rehab)
Legal and Financial Stress
- Pfizer claimed Rachel’s age (41) made tumors “expected”
- Nursing home costs for post-surgery care bankrupted her family
Injurease’s Support
- Proved 11 years of Depo-Provera use exceeded FDA-recommended duration
- Demonstrated Pfizer’s failure to update labeling after 2016 EU tumor warnings
- Won rare punitive damages for corporate misconduct
Outcome
An Illinois jury awarded $2.05 million—the largest Depo-Provera verdict to date:
✔ Future 24/7 care ($1.2M)
✔ Lost career earnings ($620K)
✔ Punitive damages ($230K)
